Open AccessDoes tumor stroma ratio of breast cancer trucut biopsy determine response to neoadjuvant therapy?
Author(s) -
Varuna Mallya,
Vishal Singh,
Navpreet Kaur,
Priyanka Yadav,
Shramana Mandal,
Nita Khurana,
Pawanindra Lal
Publication year - 2020
Publication title -
indian journal of pathology and microbiology/indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/ijpm.ijpm_793_18
Subject(s) - stroma , breast cancer , medicine , univariate analysis , oncology , biopsy , cancer , mastectomy , immunohistochemistry , multivariate analysis
We examined the prognostic value of Tumor stroma ratio (TSR) in breast tumor core biopsy (TCB) specimen to determine response to neoadjuvant therapy (NAT) prior to modified radical mastectomy (MRM).